Literature DB >> 2644097

Antithrombotic therapy for cerebrovascular disorders.

D G Sherman1, M L Dyken, M Fisher, M J Harrison, R G Hart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2644097     DOI： 10.1378/chest.95.2_supplement.140s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  8 in total

Review 1.  Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

2.  Anticoagulation in Congestive Cardiomyopathy: Steps Toward Defining the Great Unknown.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 3.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

Review 4.  Cardioversion of atrial fibrillation.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

Review 5.  Antiplatelet therapy--Part I.

Authors:  S H Goodnight; B M Coull; J H McAnulty; L M Taylor
Journal:  West J Med       Date:  1993-04

Review 6.  Risk-benefit assessment of anticoagulant therapy.

Authors:  R Harrington; J Ansell
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 7.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10

Review 8.  Aneurysm and pseudoaneurysm of the left ventricle.

Authors:  Jamal El Ouazzani; Issam Jandou
Journal:  Ann Med Surg (Lond)       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.